首页> mBio> Novel Klebsiella pneumoniae and Pseudomonas aeruginosa MAPS vaccine combining O polysaccharides and pathogen-specific proteins.

Novel Klebsiella pneumoniae and Pseudomonas aeruginosa MAPS vaccine combining O polysaccharides and pathogen-specific proteins.

导出 OA

翻译打印收藏纠错

第一作者： Mohammed N,Amin

第一单位： Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

作者： Mohammed N,Amin ^[1] ; James E,Sinclair ^[1] ; Brittany,Curtis ^[1] ; Lada,Sycheva ^[2] ; Heather,Fox ^[1] ; Myeong-Jin,Choi ^[1] ; Surekha,Shridhar ^[1] ; Jacqueline,Kolasny ^[1] ; Joseph,Nkeze ^[1] ; Ethel,Apolinario ^[1] ; Sang,Hyun ^[1] ; Nicolas,Hegerle ^[1] ; Shaichi,Sen ^[1] ; Jasnehta,Permala Booth ^[1] ; Mark,Leney ^[3] ; Deborah,Molrine ^[4] ; Greg,Saia ^[4] ; Marcela,Pasetti ^[1] ; Teresa,Broering ^[2] ; Francis,Michon ^[4] ; Richard,Malley ^[2] ; George R,Siber ^[5] ; Sharon M,Tennant ^[1] ; Donna,Ambrosino ^[4] ; Raphael,Simon ^[1] ; Alan,Cross ^[1]

作者单位： Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA. ^[1] Affinivax Inc. (a GSK company), Cambridge, Massachusetts, USA. ^[2] RRD International, Rockville, Maryland, USA. ^[3] Nosocomial Vaccines Company, Rockville, Maryland, USA. ^[4] Siber Biotechnologies LLC, New York, New York, USA. ^[5]

关键词 Klebsiella pneumoniae MAPS vaccine MrkA O polysaccharide PcrV Pseudomonas aeruginosa flagellin